Production of cytokines by alveolar and peritoneal macrophages stimulated by Aspergillus fumigatus conidia or hyphae

Journal of Medical and Veterinary Mycology

Volumn 34, Issue 1, 1996, Pages 49-56

  Taramelli, D ^a   Malabarba, M G ^a   Sala, G ^a   Basilico, N ^b   Cocuzza, G ^b  

^a UNIVERSITY OF MILAN   (Italy)

^b UNIVERSITY OF MILAN   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; INTERLEUKIN 1; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ARTICLE; ASPERGILLOSIS; ASPERGILLUS; ASPERGILLUS FUMIGATUS; CONTROLLED STUDY; IMMUNE DEFICIENCY; IMMUNE RESPONSE; LUNG ALVEOLUS MACROPHAGE; MOUSE; NONHUMAN; PERITONEUM MACROPHAGE;

ANIMALIA; ASPERGILLUS FLAVUS; ASPERGILLUS FUMIGATUS; ASPERGILLUS NIGER; ASPERGILLUS TERREUS; FUNGI;

EID: 0029914341     PISSN: 02681218     EISSN: None     Source Type: Journal    
DOI: 10.1080/02681219680000081     Document Type: Article

References (36)

1. Bennett JE. Aspergillus species. In: Mandell GL, Douglas RG. Bennett JE. eds. Principles and Practice of Infectious Diseases. 3rd edn. New York: Churchill Livingstone. 1990: 1958-62.
2. Deepe GS, Bullock WE. Immunological aspects of fungal pathogenesis. Eur J Clin Microbiol Infect Dis 1990; 9: 567-79.
3. Saral R. Candida and Aspergillus infections in immunocompromised patients: an overview. Rev Infect Dis 1991; 13: 487-92.
4. Waldorf AR, Levitz SM, Diamond RD. In vivo bronchoalveolar macrophage defense against Rhi:opus oryzae and Aspergillus fiimigatus. J Infect Dis 1984; 150: 752-60.
5. Diamond RD. Krzesicki R, Epstein B, Jao W. Damage to hyphal forms of fungi by human leukocytes in vitro. Am J Pathol 1978; 91: 313-23.
6. Schaffner A. Douglas H. Braude A. Selective protection against conidia by mononuclear and against mycelia by polymorphonuclear phagocytes in resistance to Aspergillus. J Clin Invest 1982: 69: 617-31.
7. Levitz SE, Selsted ME, Ganz T. Lehrer RI. Diamond RD. In vitro killing of spores and hyphae of Aspergillus fumigatus and Rhizopus oryzae by rabbit neutrophil cationic peptides and bronchoalveolar macrophages. J Infect Dix 1986; 154: 483-9.
8. Washburn RG. Gallin JI, Bennett JE. Oxidative killing of Aspergillus fumigatus proceeds by parallel myeloperoxidasedependent and -independent pathways. Infect Immun 1987; 55: 2088-92.
9. Sturtevant JE, Latgé JP. Interactions between conidia of Aspergillus fumigatus and human complement component C3. Infect Immun 1992; 60: 1913-8.
10. Waldorf AR. Pulmonary defense mechanisms against opportunistic fungal pathogens. In: Kurstak E, ed. Immunology o) Fungal Diseases. New York: Marcel Dekker. 1989: 243-71.
11. Ferrante A. Tumor necrosis factor alpha potentiates neutrophil antimicrobial activity: increased fungicidal activity against Torn/apsis glabrata and Candida ulbicans and associated increases in oxygen radical production and lysosomal enzyme release. Infect Immun 1989: 57: 2115-22.
12. Vassalli P. The pathophysiology of tumor necrosis factors. Ann Rev Immunol 1992; 10:411-52.
13. Fantuzzi G, Demitri MT. Ghezzi P. Differential effect of glucocorticoids on tumour necrosis factor production in mice: up-regulation by early pretreatment with dexamethasone. Clin Exp Immunol 1994: 96: 166-9.
14. Klech H. Hutter C. Costabel U. Clinical guidelines and indicators for bronchoalveolar lavage (BAL). Eur Resp Rev 1992: 2: 47-127.
15. Taramelli D. Varesio L. Activation of murine macrophages. I. Different pattern of activation by Poly I:C than by lymphokines or LPS. J Immunol 1981: 127: 58-63.
16. Espevik T. Nissen-Meyer J. A highly sensitive cell line. WEHI 164 clone 13, for measuring cytotoxic factor/tumor necrosis factor from human monocytes. J Immunol Meth 1986: 95: 99-105.
17. Tartakovsky B. Finnegan A. Muegge K, et al. IL-1 is an autocrine growth factor for T cell clones. J Immunol 1988; 141: 3863-7.
18. Ding AH, Nathan CF. Stuehr DJ. Release of reactive nitrogen intermediates and reactive oxygen intermediates from mouse peritoneal macrophages. J Immunol 1988; 141: 2407-12.
19. Manninen A. Lewis DM, Olenchock SA, et al. Interleukin 1 and its inhibition in an inflammatory reaction caused by Aspergillus umbrosus. Scuiul J Work and Environ Health 1992; 18 (Suppl. 2): 75-7.
20. Brummer E. The role of neutrophils and macrophages in host resistance to systemic fungal infections. In: Kurstak E, ed. Immunology of Fungal Diseases. New York: Marcel Dekker. 1991: 273-89.
21. Vecchiarelli A. Puliti M. Torasantucci A. Cassone A. Bistoni F. //; vitro production of tumor necrosis factor by murine splenic macrophages stimulated with mannoprotein constituents of Candida albicans cell wall. Cell Immun 1991; 134: 65-76.
22. Levitz SM. Farrel TP. Maziarz RT. Killing of Cryptococcus neojormans by human peripheral blood mononuclear cells stimulated in culture. J Infect Dis 1991: 163: 1108-13.
23. Steinshamn S. Waage A. Tumor necrosis factor and interleukin 6 in Candida albicans infection in normal and granulocytopenic mice. Infect Immun 1992: 60: 4003-8.
24. Rex JH. Bennett JE. Gallin JI, Malech HL, Decarlu ES. Melnick DA. In vivo interferon-;1 therapy augments the in vitro ability of chronic granulomatous disease neutrophils to damage Aspergillus hyphae. J Infect Dis 1991: 163: 849-52.
25. Roilides E, Walsh TJ, Pizzo PA, Rubin M. Granulocyte colonystimulating factor enhances the phagocytic and bactericidal activity of normal and defective human neutrophils. J Infect Dis 1991; 163: 579-83.
26. Schaffner A, Douglas H, Braude AI, Davis CE. Killing of Aspergillus spores depends on the anatomical source of the macrophage. Infect Immun 1983; 42: 1109-15.
27. Blasi E, Pitzurra L, Puliti E, Lanfrancone L, Bistoni F. Early differential molecular response of a macrophage cell line to yeast and hyphal forms of Candida albicans. Infect Immun 1992; 60: 832-7.
28. Torosantucci A, Bromuro C, Gomez MJ, Ausiello C, Urbani F, Cassone A. Identification of a 65-kDa mannoprotein as a main target of human cell mediated immune response to Candida albicans. J Infect Dis 1993; 168: 427-35.
29. Hearn VM, Sietsma JH. Chemical and immunological analysis of the Aspergillus fumigatus cell wall. Microbiology 1994; 140: 789-95.
30. Stynen D, Sarfati J, Goris A, et al. Rat monoclonal antibodies against Aspergillus galactomannan. Infect Immun 1992; 60: 2237-45.
31. Hector RF. Compounds active against cell walls of medically important fungi. Clin Microbiol Rev 1993; 6: 1-21.
32. Braun PC, Calderone RA. Chitin synthesis in Candida albicans: comparison of yeast and hyphal forms. / Bacterial 1978; 133: 1472-7.
33. Sullivan P, Yin CY, Molloy C, Templeton M, Shepherd M. An analysis of the metabolism and cell wall composition of Candida albicans during germ-tube formation. Can J Microbiol 1983; 29: 1514-25.
34. Cameron ML, Granger DL, Weinberg JB, Kozumbo WJ, Koren SH. Human alveolar and peritoneal macrophages mediate fungistasis independently of L-arginine oxidation to nitrite or nitrate. Am Rev Resp Dis 1990; 142: 1313-9.
35. Kurup V, Mauze S, Choi H, Seymour B, Coffman R. A murine model of allergic bronchopulmonary aspergillosis with elevated eosinophils and IgE. J Immunol 1992; 148: 3783-8.
36. Roilides E, Holmes A, Blake C, Pizzo PA, Walsh TJ. Impairment of neutrophil antifungal activity against hyphae of Aspergillus fumigatus in children infected with human immunodeficiency virus. J Infect Dis 1993; 167: 905-11.